6OBH image
Entry Detail
PDB ID:
6OBH
Keywords:
Title:
Structure of HIV-1 CA 1/2-hexamer
Biological Source:
PDB Version:
Deposition Date:
2019-03-20
Release Date:
2019-08-28
Method Details:
Experimental Method:
Resolution:
2.96 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CA
Mutations:A14C, W184A, M185A
Chain IDs:A, D
Chain Length:232
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:CA
Mutations:E45C, T54C, W184A, M185A
Chain IDs:B, E
Chain Length:232
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:CA
Mutations:A42C, W184A, M185A
Chain IDs:C, F
Chain Length:232
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Ligand Molecules
Primary Citation
Modular HIV-1 Capsid Assemblies Reveal Diverse Host-Capsid Recognition Mechanisms.
Cell Host Microbe 26 203 216.e6 (2019)
PMID: 31415753 DOI: 10.1016/j.chom.2019.07.007

Abstact

The HIV-1 capsid is an ordered protein shell that houses the viral genome during early infection. Its expansive surface consists of an ordered and interfacing array of capsid protein hexamers and pentamers that are recognized by numerous cellular proteins. Many of these proteins recognize specific, assembled capsid interfaces not present in unassembled capsid subunits. We used protein-engineering tools to capture diverse capsid assembly intermediates. We built a repertoire of capsid assemblies (ranging from two to 42 capsid protein molecules) that recreate the various surfaces in infectious capsids. These assemblies reveal unique capsid-targeting mechanisms for each of the anti-HIV factors, TRIMCyp, MxB, and TRIM5α, linked to inhibition of virus uncoating and nuclear entry, as well as the HIV-1 cofactor FEZ1 that facilitates virus intracellular trafficking. This capsid assembly repertoire enables elucidation of capsid recognition modes by known capsid-interacting factors, identification of new capsid-interacting factors, and potentially, development of capsid-targeting therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures